000 | 01737 a2200541 4500 | ||
---|---|---|---|
005 | 20250516072923.0 | ||
264 | 0 | _c20120507 | |
008 | 201205s 0 0 eng d | ||
022 | _a1477-0962 | ||
024 | 7 |
_a10.1177/0961203311429817 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPerdan-Pirkmajer, K | |
245 | 0 | 0 |
_aAutoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease. _h[electronic resource] |
260 |
_bLupus _cFeb 2012 |
||
300 |
_a175-83 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdjuvants, Immunologic _xadverse effects |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAutoantibodies _xblood |
650 | 0 | 4 |
_aAutoimmune Diseases _xblood |
650 | 0 | 4 |
_aAutoimmunity _ximmunology |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammation _xblood |
650 | 0 | 4 |
_aInfluenza A Virus, H1N1 Subtype _ximmunology |
650 | 0 | 4 |
_aInfluenza Vaccines _xadverse effects |
650 | 0 | 4 |
_aInfluenza, Human _xprevention & control |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aRheumatic Diseases _xblood |
650 | 0 | 4 |
_aVaccination _xadverse effects |
700 | 1 | _aThallinger, G G | |
700 | 1 | _aSnoj, N | |
700 | 1 | _aČučnik, S | |
700 | 1 | _aŽigon, P | |
700 | 1 | _aKveder, T | |
700 | 1 | _aLogar, D | |
700 | 1 | _aPraprotnik, S | |
700 | 1 | _aTomšič, M | |
700 | 1 | _aSodin-Semrl, S | |
700 | 1 | _aAmbrožič, A | |
773 | 0 |
_tLupus _gvol. 21 _gno. 2 _gp. 175-83 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/0961203311429817 _zAvailable from publisher's website |
999 |
_c21451712 _d21451712 |